Buy 4-Bromo-2-fluorobenzoic Acid

Name: 4-Bromo-2-fluorobenzoic Acid
Brand: Sarchem Labs
SKU: S2869

CAS: 112704-79-7

SKU: S2869

4-Bromo-2-fluorobenzoic acid | SKU: S2869

Synonyms: none listed beyond the systematic name

4-Bromo-2-fluorobenzoic Acid is a halogenated benzoic acid that Sarchem Labs supplies as a solid for pharmaceutical intermediate manufacturing. Every lot ships with a Certificate of Analysis and Safety Data Sheet.

Request Quote — S2869

Specifications

Appearance	N/A
Content of Zinc	N/A
Boiling Point	N / A
Melting Point	211–215°C
Vapor Pressure	N/A
% Volatile by Weight	N/A
Solubility in Water	N/A
Density	N/A
pH of Liquid, Typical (10% soln)	N/A
Specific Gravity Approx	N/A
Odor	N/A
pH	N/A
Flash Point	N/A
Ignition temperature	N/A
Lower exposure limit	N/A
Upper exposure limit	N/A
Color	White-Yellow
Linear Formula	BrC6H3(F)COOH
Formula Weight	219.01
Physical Form	Crystal-powder at 20°C
Chemical Name or Material	4-Bromo-2-fluorobenzoic Acid
Molecular Weight	219.01 g/mol
Assay	97%
CAS Number	112704-79-7
NACRES	NA.22
PubChem Substance ID	24864450
UNSPSC Code	12352100
MDL Number	MFCD00143263
Applications	Oncology drug manufacturing — this compound has been identified as a related compound/impurity reference relevant to enzalutamide (Xtandi), an approved prostate cancer drug

Applications

Oncology drug manufacturing — this compound has been identified as a related compound/impurity reference relevant to enzalutamide (Xtandi), an approved prostate cancer drug

Biaryl pharmaceutical intermediate manufacturing (palladium-mediated coupling with aryl boronic acids)

Product Description

What is 4-Bromo-2-fluorobenzoic Acid?

This compound is a benzoic acid substituted with both bromine and fluorine. The bromine provides a handle for palladium-mediated cross-coupling to build biaryl structures, a common step in constructing complex pharmaceutical intermediates.

Uses of 4-Bromo-2-fluorobenzoic Acid

This compound is used in pharmaceutical manufacturing as a building block for biaryl intermediates via palladium-catalyzed coupling with aryl boronic acids, and is specifically documented as relevant to enzalutamide-related oncology drug chemistry.